3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
2
Castration Resistant Metastatic Prostate Cancer
2
Castration-resistant Prostate Cancer
1
Castration-Resistant Prostate Carcinoma
1
Interventions
enzalutamide
3
Abiraterone Acetate
2
testosterone enanthate
1
pembrolizumab
1
disitamab vedotin
1
abiraterone
1
Radium-223
1
Prednisone
1
Ketoconazole
1
Hydrocortisone
1
Flutamide
1
Calcitriol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Castration-resistant Prostate Cancer
×
testosterone enanthate
×
Clear all
NCT03522064
2026-04-23
HiTeCH
St Vincent's Hospital, Sydney
Phase 2
Recruiting
30 enrolled